The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
PRMTs and Arginine Methylation: Cancer’s Best-Kept Secret?
Abstract
Post-translational modification (PTM) of proteins is vital for increasing proteome diversity and maintaining cellular homeostasis. If the writing, reading, and removal of modifications are not controlled, cancer can develop. Arginine methylation is an understudied modification that is increasingly associated with cancer progression. Consequently protein arginine methyltransferases (PRMTs), the writers of arginine methylation, have rapidly gained interest as novel drug targets. However, for clinical success a deep mechanistic understanding of the biology of PRMTs is required. In this review we focus on advances made regarding the role of PRMTs in stem cell biology, epigenetics, splicing, immune surveillance and the DNA damage response, and highlight the rapid rise of specific inhibitors that are now in clinical trials for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2005) · Science · doi:10.1126/science.1108297 · Cited by 1,424
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Białkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0140 · Cited by 1,310
Double-strand break repair: 53BP1 comes into focus
Panier, S., & Boulton, S. J. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3719 · Cited by 1,098
Protein arginine methyltransferases and cancer
Yang, Y., & Bedford, M. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3409 · Cited by 1,083
Regulatory T cells in tumor immunity
Nishikawa, H., & Sakaguchi, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25429 · Cited by 944
Histone Deimination Antagonizes Arginine Methylation
Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage, H., Hagiwara, T., Yamada, M., Schneider, R., Gregory, P. D., Tempst, P., Bannister, A. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.08.020 · Cited by 839
Wang, H., Huang, Z.-Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P., et al. (2001) · Science · doi:10.1126/science.1060781 · Cited by 805
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
Kryukov, G. V., Wilson, F. H., Ruth, J. R., Paulk, J., Tsherniak, A., Marlow, S. E., Vazquez, F., Weir, B. A., Fitzgerald, M. E., Tanaka, M., et al. (2016) · Science · doi:10.1126/science.aad5214 · Cited by 688
Thandapani, P., O’Connor, T. R., Bailey, T. L., & Richard, S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.021 · Cited by 685
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
Mavrakis, K. J., McDonald, E. R., Schlabach, M. R., Billy, E., Hoffman, G. R., deWeck, A., Ruddy, D. A., Venkatesan, K., Yu, J., McAllister, G., et al. (2016) · Science · doi:10.1126/science.aad5944 · Cited by 607
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Chan-Penebre, E., Kuplast, K. G., Majer, C. R., Boriack-Sjodin, P. A., Wigle, T. J., Johnston, L. D., Rioux, N., Munchhof, M. J., Jin, L., Jacques, S. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1810 · Cited by 569
Zhao, Q., Rank, G., Tan, Y. T., Li, H., Moritz, R. L., Simpson, R. J., Cerruti, L., Curtis, D. J., Patel, D. J., Allis, C. D., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1568 · Cited by 535
Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination
Tang, J., Cho, N. W., Cui, G., Manion, E. M., Shanbhag, N. M., Botuyan, M. V., Mer, G., & Greenberg, R. A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2499 · Cited by 521
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
Stopa, N., Krebs, J. E., & Shechter, D. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1847-9 · Cited by 513
Di Lorenzo, A., & Bedford, M. T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.010 · Cited by 509
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Prieto-Vila, M., Takahashi, R.-U., Usuba, W., Kohama, I., & Ochiya, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122574 · Cited by 508
Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive
Guccione, E., Bassi, C., Casadio, F., Martinato, F., Cesaroni, M., Schuchlautz, H., Lüscher, B., & Amati, B. (2007) · Nature · doi:10.1038/nature06166 · Cited by 491
MTAP deletions in cancer create vulnerability to targeting of the MAT2A/PRMT5/RIOK1 axis
Marjon, K., Cameron, M. J., Quang, P., Clasquin, M. F., Mandley, E., Kunii, K., McVay, M., Choe, S., Kernytsky, A., Gross, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.043 · Cited by 485
DNA repair pathways and cisplatin resistance: an intimate relationship
Rocha, C. R. R., Silva, M. M., Quinet, A., Cabral-Neto, J. B., & Menck, C. F. M. (2018) · Clinics · doi:10.6061/clinics/2018/e478s · Cited by 446
Otani, J., Nankumo, T., Arita, K., Inamoto, S., Ariyoshi, M., & Shirakawa, M. (2009) · EMBO reports · doi:10.1038/embor.2009.218 · Cited by 414
The Arginine Methyltransferase CARM1 Regulates the Coupling of Transcription and mRNA Processing
Cheng, D., Côté, J., Shaaban, S., & Bedford, M. T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.019 · Cited by 387
Chen, X., Chen, R.-X., Wei, W.-S., Li, Y.-H., Feng, Z.-H., Tan, L., Chen, J.-W., Yuan, G.-J., Chen, S.-L., Guo, S.-J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1270 · Cited by 382
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Koh, C. M., Bezzi, M., Low, D. H. P., Ang, W. X., Teo, S. X., Gay, F. P. H., Al-Haddawi, M., Tan, S. Y., Osato, M., Sabò, A., et al. (2015) · Nature · doi:10.1038/nature14351 · Cited by 380
Tee, W.-W., Pardo, M., Theunissen, T. W., Yu, L., Choudhary, J. S., Hajkova, P., & Surani, M. A. (2010) · Genes & Development · doi:10.1101/gad.606110 · Cited by 356
Pawlak, M. R., Scherer, C. A., Chen, J., Roshon, M. J., & Ruley, H. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4859-4869.2000 · Cited by 355
Lee, S. C.-W., Dvinge, H., Kim, E., Cho, H., Micol, J.-B., Chung, Y. R., Durham, B. H., Yoshimi, A., Kim, Y. J., Thomas, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4097 · Cited by 347
Migliori, V., Müller, J., Phalke, S., Low, D., Bezzi, M., Mok, W. C., Sahu, S. K., Gunaratne, J., Capasso, P., Bassi, C., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2209 · Cited by 345
Small Molecule Regulators of Protein Arginine Methyltransferases
Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., & Bedford, M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401853200 · Cited by 339
Cancer stem cells, cancer cell plasticity and radiation therapy
Vlashi, E., & Pajonk, F. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.001 · Cited by 327
Bezzi, M., Teo, S. X., Muller, J., Mok, W. C., Sahu, S. K., Vardy, L. A., Bonday, Z. Q., & Guccione, E. (2013) · Genes & Development · doi:10.1101/gad.219899.113 · Cited by 300
Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection
Densham, R. M., Garvin, A. J., Stone, H. R., Strachan, J., Baldock, R. A., Daza-Martin, M., Fletcher, A., Blair-Reid, S., Beesley, J., Johal, B., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3236 · Cited by 290
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
Eram, M. S., Shen, Y., Szewczyk, M. M., Wu, H., Senisterra, G., Li, F., Butler, K. V., Kaniskan, H. Ü., Speed, B. A., dela Seña, C., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00839 · Cited by 289
Liu, F., Zhao, X., Perna, F., Wang, L., Koppikar, P., Abdel-Wahab, O., Harr, M. W., Levine, R. L., Xu, H., Tefferi, A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.020 · Cited by 273
Yang, Y., McBride, K. M., Hensley, S., Lu, Y., Chedin, F., & Bedford, M. T. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.01.011 · Cited by 252
Aggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H., Gurung, B., Nakagawa, H., Herlyn, M., Hua, X., Rustgi, A. K., McMahon, S. B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.012 · Cited by 242
Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases
Walport, L. J., Hopkinson, R. J., Chowdhury, R., Schiller, R., Ge, W., Kawamura, A., & Schofield, C. J. (2016) · Nature Communications · doi:10.1038/ncomms11974 · Cited by 236
PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145
Yang, Y., Hadjikyriacou, A., Xia, Z., Gayatri, S., Kim, D., Zurita-Lopez, C., Kelly, R., Guo, A., Li, W., Clarke, S. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms7428 · Cited by 235
Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control
Boisvert, F.-M., Déry, U., Masson, J.-Y., & Richard, S. (2005) · Genes & Development · doi:10.1101/gad.1279805 · Cited by 231
Tip60: Connecting chromatin to DNA damage signaling
Sun, Y., Jiang, X., & Price, B. D. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10931 · Cited by 230
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes
Hamard, P.-J., Santiago, G. E., Liu, F., Karl, D. L., Martinez, C., Man, N., Mookhtiar, A. K., Duffort, S., Greenblatt, S., Verdun, R. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.002 · Cited by 222
Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs
Meister, G. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf585 · Cited by 213
Yu, Z., Chen, T., Hébert, J., Li, E., & Richard, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00042-09 · Cited by 208
Braun, C. J., Stanciu, M., Boutz, P. L., Patterson, J. C., Calligaris, D., Higuchi, F., Neupane, R., Fenoglio, S., Cahill, D. P., Wakimoto, H., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.018 · Cited by 208
Gerhart, S. V., Kellner, W. A., Thompson, C., Pappalardi, M. B., Zhang, X.-P., Montes de Oca, R., Penebre, E., Duncan, K., Boriack-Sjodin, A., Le, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28002-y · Cited by 206
MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
Cobbold, M., De La Peña, H., Norris, A., Polefrone, J. M., Qian, J., English, A. M., Cummings, K. L., Penny, S., Turner, J. E., Cottine, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006061 · Cited by 204
Baldwin, G. S., & Carnegie, P. R. (1971) · Science · doi:10.1126/science.171.3971.579 · Cited by 204
Chiang, K., Zielinska, A. E., Shaaban, A. M., Sanchez-Bailon, M. P., Jarrold, J., Clarke, T. L., Zhang, J., Francis, A., Jones, L. J., Smith, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.096 · Cited by 204
Self-citationPolo, S. E., Blackford, A. N., Chapman, J. R., Baskcomb, L., Gravel, S., Rusch, A., Thomas, A., Blundred, R., Smith, P., Kzhyshkowska, J., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.035 · Cited by 184
Bonday, Z. Q., Cortez, G. S., Grogan, M. J., Antonysamy, S., Weichert, K., Bocchinfuso, W. P., Li, F., Kennedy, S., Li, B., Mader, M. M., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00014 · Cited by 183
Chen, H., Lorton, B., Gupta, V, & Shechter, D. (2017) · Oncogene · doi:10.1038/onc.2016.205 · Cited by 181
Boisvert, F., Rhie, A., Richard, S., & Doherty, A. J. (2005) · Cell Cycle · doi:10.4161/cc.4.12.2250 · Cited by 176
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
Zhang, L., Tran, N.-T., Su, H., Wang, R., Lu, Y., Tang, H., Aoyagi, S., Guo, A., Khodadadi-Jamayran, A., Zhou, D., et al. (2015) · eLife · doi:10.7554/elife.07938 · Cited by 176
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia
Cheung, N., Fung, T. K., Zeisig, B. B., Holmes, K., Rane, J. K., Mowen, K. A., Finn, M. G., Lenhard, B., Chan, L. C., & So, C. W. E. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.007 · Cited by 175
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
Jin, Y., Zhou, J., Xu, F., Jin, B., Cui, L., Wang, Y., Du, X., Li, J., Li, P., Ren, R., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85239 · Cited by 171
Clarke, T. L., Sanchez-Bailon, M. P., Chiang, K., Reynolds, J. J., Herrero-Ruiz, J., Bandeiras, T. M., Matias, P. M., Maslen, S. L., Skehel, J. M., Stewart, G. S., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.019 · Cited by 171
Self-citationTarighat, S. S., Santhanam, R., Frankhouser, D., Radomska, H. S., Lai, H., Anghelina, M., Wang, H., Huang, X., Alinari, L., Walker, A., et al. (2016) · Leukemia · doi:10.1038/leu.2015.308 · Cited by 169
Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis
Liu, F., Cheng, G., Hamard, P.-J., Greenblatt, S. M., Wang, L., Man, N., Perna, F., Xu, H., Tadi, M., Luciani, L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81749 · Cited by 168
BRCA1/2 mutations and triple negative breast cancers
Peshkin, B. N., Alabek, M. L., & Isaacs, C. (2011) · Breast Disease · doi:10.3233/bd-2010-0306 · Cited by 166
Target-Based Approach to Inhibitors of Histone Arginine Methyltransferases
Spannhoff, A., Heinke, R., Bauer, I., Trojer, P., Metzger, E., Gust, R., Schüle, R., Brosch, G., Sippl, W., & Jung, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061250e · Cited by 163
Drew, A. E., Moradei, O. M., Jacques, S. L., Rioux, N., Boriack-Sjodin, A., Allain, C. J., Scott, M. P., Jin, L., Raimondi, A., Handler, J. L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-18446-z · Cited by 162
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Duncan, K. W., Rioux, N., Boriack-Sjodin, P. A., Munchhof, M. J., Reiter, L. A., Majer, C. R., Jin, L., Johnston, L. D., Chan-Penebre, E., Kuplast, K. G., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00380 · Cited by 160
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
Nakayama, K., Szewczyk, M. M., Seña, C. D., Wu, H., Dong, A., Zeng, H., Li, F., de Freitas, R. F., Eram, M. S., Schapira, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24883 · Cited by 158
Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins
Gonsalvez, G. B., Tian, L., Ospina, J. K., Boisvert, F., Lamond, A. I., & Matera, A. G. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702147 · Cited by 151
Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding
Guo, Z., Zheng, L., Xu, H., Dai, H., Zhou, M., Pascua, M. R., Chen, Q. M., & Shen, B. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.422 · Cited by 148
Kanıskan, H. Ü., Szewczyk, M. M., Yu, Z., Eram, M. S., Yang, X., Schmidt, K. T., Luo, X., Dai, M., He, F., Zang, I., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412154 · Cited by 148
Shia, W.-J., Okumura, A. J., Yan, M., Sarkeshik, A., Lo, M., Matsuura, S., Komeno, Y., Zhao, X., Nimer, S. D., Yates, J. R., et al. (2012) · Blood · doi:10.1182/blood-2011-04-347476 · Cited by 145
Ribosomal Protein rpS2 Is Hypomethylated in PRMT3-deficient Mice
Swiercz, R., Cheng, D., Kim, D., & Bedford, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609778200 · Cited by 143
Gao, Y., Zhao, Y., Zhang, J., Yang, L., Liu, X., Geng, P., Huang, B., Zhang, Y., & Lü, J. (2016) · Scientific Reports · doi:10.1038/srep19874 · Cited by 141
Localization of Methylated Arginine in the A1 Protein from Myelin
Brostoff, S. W., & EYLAR, E. H. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.765 · Cited by 140
Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor
Neault, M., Mallette, F. A., Vogel, G., Michaud‐Levesque, J., & Richard, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks764 · Cited by 140
CARM1 is Required in Embryonic Stem Cells to Maintain Pluripotency and Resist Differentiation
Wu, Q., Bruce, A. W., Jędrusik, A., Ellis, P. D., Andrews, R., Langford, C., Glover, D. M., & Zernicka‐Goetz, M. (2009) · Stem Cells · doi:10.1002/stem.131 · Cited by 135
Wang, R., Islam, K., Liu, Y., Zheng, W., Tang, H., Lailler, N., Blum, G., Deng, H., & Luo, M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja309412s · Cited by 135
Wang, R., Zheng, W., Yu, H., Deng, H., & Luo, M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2006719 · Cited by 129
Jiang, H., Zhou, Z., Jin, S., Xu, K., Zhang, H., Xu, J., Sun, Q., Wang, J., & Xu, J. (2018) · Cancer Science · doi:10.1111/cas.13598 · Cited by 126
Dong, F., Li, Q., Yang, C., Huo, D., Wang, X., Ai, C., Kong, Y., Sun, X., Wang, W., Zhou, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06968-7 · Cited by 126
Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1
Higashimoto, K., Kuhn, P., Desai, D., Cheng, X., & Xu, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610792104 · Cited by 124
PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem Cells
Tan, D. Q., Li, Y., Yang, C., Li, J., Tan, S. H., Chin, D. W. L., Nakamura‐Ishizu, A., Yang, H. H., & Suda, T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.001 · Cited by 124
The MRE11 GAR motif regulates DNA double-strand break processing and ATR activation
Yu, Z., Vogel, G., Coulombe, Y., Dubeau, D., Spehalski, E. I., Hébert, J., Ferguson, D. O., Masson, J., & Richard, S. (2011) · Cell Research · doi:10.1038/cr.2011.128 · Cited by 117
Li, X., Hu, X., Patel, B., Zhou, Z., Liang, S. Y., Ybarra, R., Qiu, Y., Felsenfeld, G., Bungert, J., & Huang, S. (2010) · Blood · doi:10.1182/blood-2009-07-236059 · Cited by 116
Chan, L.-H., Zhou, L., Ng, K. Y., Wong, T. L., Lee, T. K., Sharma, R., Loong, J. H. C., Ching, Y. P., Yuan, Y., Xie, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.053 · Cited by 116
PRMT1 loss sensitizes cells to PRMT5 inhibition
Gao, G., Zhang, L., Villarreal, O. D., He, W., Su, D., Bedford, E., Moh, P., Shen, J., Shi, X., Bedford, M. T., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz200 · Cited by 114
Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response
Szewczyk, M. M., Ishikawa, Y., Organ, S. L., Sakai, N., Li, F., Halabelian, L., Ackloo, S. Z., Couzens, A. L., Eram, M. S., Dilworth, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16271-z · Cited by 111
The oxygenase Jmjd6–a case study in conflicting assignments
Böttger, A., Islam, M. S., Chowdhury, R., Schofield, C. J., & Wolf, A. (2015) · Biochemical Journal · doi:10.1042/bj20150278 · Cited by 108
Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1
Yan, L., Yan, C., Qian, K., Su, H., Kofsky-Wofford, S. A., Lee, W.-C., Zhao, X., Ho, M., Ivanov, I. N., & Zheng, Y. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401884z · Cited by 106
Carascossa, S., Dudek, P., Cenni, B., Briand, P.-A., & Picard, D. (2010) · Genes & Development · doi:10.1101/gad.568410 · Cited by 105
Methylation of MRE11 Regulates its Nuclear Compartmentalization
Boisvert, F., Hendzel, M. J., Masson, J., & Richard, S. (2005) · Cell Cycle · doi:10.4161/cc.4.7.1830 · Cited by 104
Hadjikyriacou, A., Yang, Y., Espejo, A. B., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.659433 · Cited by 102
Automethylation of CARM1 allows coupling of transcription and mRNA splicing
Kuhn, P., Chumanov, R. S., Wang, Y., Ge, Y., Burgess, R. R., & Xu, W. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1246 · Cited by 102
JMJD6 Regulates ERα Methylation on Arginine
Poulard, C., Rambaud, J., Hussein, N., Corbo, L., & Romancer, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087982 · Cited by 102
PRMT5-mediated regulation of developmental myelination
Scaglione, A., Patzig, J., Liang, J., Frawley, R., Bok, J., Mela, A., Yattah, C., Zhang, J., Teo, S. X., Zhou, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04863-9 · Cited by 100
Discovery of a Dual PRMT5–PRMT7 Inhibitor
Smil, D. V., Eram, M. S., Li, F., Kennedy, S., Szewczyk, M. M., Brown, P. J., Baršytė-Lovejoy, D., Arrowsmith, C. H., Vedadi, M., & Schapira, M. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500467h · Cited by 99
Shen, Y., Szewczyk, M. M., Eram, M. S., Smil, D. V., Kanıskan, H. Ü., de Freitas, R. F., Senisterra, G. A., Li, F., Schapira, M., Brown, P. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01033 · Cited by 98
PRMT7 Preserves Satellite Cell Regenerative Capacity
Blanc, R. S., Vogel, G., Chen, T., Crist, C., & Richard, S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.022 · Cited by 97
Crystal Structure of TDRD3 and Methyl-Arginine Binding Characterization of TDRD3, SMN and SPF30
Liu, K., Guo, Y., Liu, H., Bian, C., Lam, R., Liu, Y., MacKenzie, F., Rojas, L. A., Reinberg, D., Bedford, M. T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030375 · Cited by 96
He, W., Ma, X., Yang, X. Y., Zhao, Y., Qiu, J., & Hang, H. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1264 · Cited by 92
PRMT7 as a unique member of the protein arginine methyltransferase family: A review
Jain, K., & Clarke, S. G. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.02.014 · Cited by 91
Biochemical Control of CARM1 Enzymatic Activity by Phosphorylation
Feng, Q. F., He, B., Jung, S. Y., Song, Y., Qin, J., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065524 · Cited by 87
The arginine methyltransferase PRMT2 binds RB and regulates E2F function
Yoshimoto, T., Boehm, M., Olive, M., Crook, M. F., San, H., Langenickel, T., & Nabel, E. G. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.001 · Cited by 87
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis
Greenblatt, S. M., Man, N., Hamard, P.-J., Asai, T., Karl, D. L., Martínez, C., Bilbao, D., Stathias, V., Jermakowicz, A. M., Duffort, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.007 · Cited by 87
Katsuno, Y., Qin, J., Osés-Prieto, J. A., Wang, H., Jackson‐Weaver, O., Zhang, T., Lamouille, S., Wu, J., Burlingame, A. L., Xu, J., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002027 · Cited by 83
Arginine Methylation by PRMT1 Regulates Muscle Stem Cell Fate
Blanc, R. S., Vogel, G., Li, X., Yu, Z., Li, S., & Richard, S. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00457-16 · Cited by 79
Nagai, Y., Ji, M. Q., Zhu, F., Xiao, Y., Tanaka, Y., Kambayashi, T., Fujimoto, S., Goldberg, M. M., Zhang, H., Li, B., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00174 · Cited by 78
A Germ Cell-specific Gene, Prmt5, Works in Somatic Cell Reprogramming
Nagamatsu, G., Kosaka, T., Kawasumi, M., Kinoshita, T., Takubo, K., Akiyama, H., Sudo, T., Kobayashi, T., Oya, M., & Suda, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216390 · Cited by 77
Kim, D., Lim, S.-K., Park, M.-J., Choi, J., Kim, J., Han, H. J., Yoon, K. C., Kim, K., Lim, J. H., & Park, S. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.008 · Cited by 76
Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy
Smith, E. M., Zhou, W., Shindiapina, P., Sif, S., Li, C., & Baiocchi, R. A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1474203 · Cited by 76
GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1
Vadnais, C., Chen, R., Fraszczak, J., Yu, Z., Boulais, J., Pinder, J. B., Frank, D., Khandanpour, C., Hébert, J., Dellaire, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03817-5 · Cited by 75
Arginine methylation controls the strength of γc-family cytokine signaling in T cell maintenance
Inoue, M., Okamoto, K., Terashima, A., Nitta, T., Muro, R., Negishi‐Koga, T., Kitamura, T., Nakashima, T., & Takayanagi, H. (2018) · Nature Immunology · doi:10.1038/s41590-018-0222-z · Cited by 74
Ying, Z., Mei, M., Zhang, P., Liu, C., He, H., Gao, F., & Bao, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500224 · Cited by 73
CSNK1a1 Regulates PRMT1 to Maintain the Progenitor State in Self-Renewing Somatic Tissue
Bao, X., Siprashvili, Z., Zarnegar, B. J., Shenoy, R. M., Rios, E. J., Nady, N., Qu, K., Mah, A., Webster, D. E., Rubin, A. J., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.08.021 · Cited by 71
Lee, S.-H., Chen, T., Dhar, S. S., Gu, B., Chen, K., Kim, Y. Z., Li, W., & Lee, M. G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw788 · Cited by 68
de Freitas, R. F., Eram, M. S., Smil, D. V., Szewczyk, M. M., Kennedy, S., Brown, P. J., Santhakumar, V., Baršytė-Lovejoy, D., Arrowsmith, C. H., Vedadi, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00668 · Cited by 67
Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases
Jain, K., Jin, C. Y., & Clarke, S. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706978114 · Cited by 66
Effects of a novel arginine methyltransferase inhibitor on T‐helper cell cytokine production
Bonham, K. S., Hemmers, S., Lim, Y., Hill, D. M., Finn, M. G., & Mowen, K. A. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07623.x · Cited by 65
PRMT8 as a phospholipase regulates Purkinje cell dendritic arborization and motor coordination
Kim, J., Park, K.-E., Ishida, J., Kako, K., Hamada, J., Kani, S., Takeuchi, M., Namiki, K., Fukui, H., Fukuhara, S., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500615 · Cited by 65
Wang, C., Jiang, H., Jin, J., Xie, Y., Chen, Z., Zhang, H., Lian, F., Liu, J. Y.-C., Zhang, C., Ding, H., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01134 · Cited by 63
Singhroy, D. N., Mesplède, T., Sabbah, A., Quashie, P., Falgueyret, J., & Wainberg, M. (2013) · Retrovirology · doi:10.1186/1742-4690-10-73 · Cited by 62
Zhang, Z., Nikolai, B. C., Gates, L. A., Jung, S. Y., Siwak, E. B., He, B., Rice, A. P., O’Malley, B. W., & Feng, Q. F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx550 · Cited by 62
Hu, H., Owens, E. A., Su, H., Yan, L., Levitz, A., Zhao, X., Henary, M., & Zheng, Y. G. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501452j · Cited by 58
RVBs Are Required for Assembling a Functional TIP60 Complex
Jha, S., Gupta, A. K., Dar, A., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01567-12 · Cited by 57
LKB1 regulates PRMT5 activity in breast cancer
Lattouf, H., Kassem, L. M. H., Jacquemetton, J., Choucair, A., Poulard, C., Trédan, O., Corbo, L., Diab‐Assaf, M., Hussein, N., Treilleux, I., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31909 · Cited by 54
Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells
Kagoya, Y., Saijo, H., Matsunaga, Y., Guo, T., Saso, K., Anczurowski, M., Wang, C.-H., Sugata, K., Murata, K., Butler, M. O., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.09.011 · Cited by 53
Penney, J., Seo, J., Kritskiy, O., Elmsaouri, S., Gao, F., Pao, P., Su, S. C., & Tsai, L. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0591-17.2017 · Cited by 47
Li, Z., Yu, J., Hosohama, L., Nee, K., Gkountela, S., Chaudhari, S., Cass, A. A., Xiao, X. G., & Clark, A. T. (2014) · The EMBO Journal · doi:10.15252/embj.201489319 · Cited by 45
Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress
Yuniati, L., van der Meer, L. T., Tijchon, E. J. H., Schenau, D. V. I., van Emst, L., Levers, M., Palit, S. A. L., Rodenbach, C., Poelmans, G., Hoogerbrugge, P. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6519 · Cited by 45
Li, J., Zhao, Z., Carter, C., Ehrlich, L. I. R., Bedford, M. T., & Richie, E. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102513 · Cited by 41
Hellmuth, S., Gutiérrez‐Caballero, C., Llano, E., Pendás, A. M., & Stemmann, O. (2018) · The EMBO Journal · doi:10.15252/embj.201899184 · Cited by 39
Jeong, H., Park, S., Choi, J.-J., Go, Y.-H., Hong, S.-K., Kwon, O., Shin, J.-G., Kim, R.-K., Lee, M., Lee, S., et al. (2017) · Stem Cells · doi:10.1002/stem.2642 · Cited by 38
Wu, M., Lin, P., Lin, L., Chen, D., Yang, X., Xu, L., Zhou, B., Wang, C., Zhang, Y., Luo, C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802585rr · Cited by 36
Arginine (Di)methylated Human Leukocyte Antigen Class I Peptides Are Favorably Presented by HLA-B*07
Marino, F., Mommen, G. P. M., Jekő, A., Meiring, H. D., den Brink, J. A. M. V. G.-V., Scheltema, R. A., van Els, C. A. C. M., & Heck, A. J. R. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00528 · Cited by 35
Lai, Y., Li, J., Li, X., & Zou, C. (2017) · Journal of Cell Science · doi:10.1242/jcs.206904 · Cited by 35
Chen, T., Lee, S.-H., Dhar, S. S., & Lee, M. G. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000425 · Cited by 23
Goyal, A., Chavez, S. L., & Pera, R. A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082838 · Cited by 14
Jarmalavicius, S., Trefzer, U., & Walden, P. (2009) · The FASEB Journal · doi:10.1096/fj.09-136283 · Cited by 12
Cited by
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Wu, Q., Schapira, M., Arrowsmith, C. H., & Barsyte-Lovejoy, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00159-8 · Cited by 419
Targeting epigenetic regulators to overcome drug resistance in cancers
Wang, N., Ma, T., & Yu, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01341-7 · Cited by 311
Protein arginine methyltransferases: promising targets for cancer therapy
Hwang, J. W., Cho, Y., Bae, G.-U., Kim, S.-N., & Kim, Y. K. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00613-y · Cited by 268
Solleder, M., Guillaume, P., Racle, J., Michaux, J., Pak, H.-S., Müller, M., Coukos, G., Bassani-Sternberg, M., & Gfeller, D. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001641 · Cited by 68
Metadata
- Authors
- Jarrold, J., & Davies, C. C.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 25
- Issue
- 11
- Pages
- 993-1009
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2949815414
- Cited by
- 337
- References
- 139
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.